Repurposing PD-L1 Inhibitors for Obesity-Related Bone Loss
Beyond Oncology: How PD-L1 Inhibitors Are Redefining the Treatment of Obesity-Related Bone Loss For decades, the medical community operated under a comforting fallacy: that the extra weight associated with obesity provided a “mechanical shield” for the skeleton, potentially protecting against osteoporosis. However, emerging research is shattering this myth, revealing that obesity doesn’t protect the bone—it … Read more